SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) OverviewSAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Net Income
Profitability analysis for BCYPU.
Quarterly Net Income
-$18.87M
↓ 263.09% YoY
As of Mar 2026
Annual Net Income (TTM)
-$398429.00
↑ 98.4% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...